Li Liu

机构：Central South University, Pfizer (United States), Hunan Cancer Hospital, Buchang Pharma (China), First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Nanchong Central Hospital · ORCID：0000-0002-3275-2499

发表论文 234 篇 · 总被引 3614 次 · h-index 34

代表论文

• NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity (2025 · Nature · 被引 53)
• Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer (2025 · Proceedings of the National Academy of Sciences · 被引 13)
• Development and application of a Phenothiazine-Based fluorescent probe for distinguishing hydrogen sulfide and hypochlorite in oxidative stress (2025 · Microchemical Journal · 被引 12)
• Establishment and maturation of gut microbiota in White King pigeon squabs: role of pigeon milk (2025 · Frontiers in Microbiology · 被引 6)
• A novel fluorescent probe for rapid and selective detection of fluoride ions in living cells (2025 · Analytical Methods · 被引 5)
• Distillers’ grains biochar derived iron catalyst for remediation of tetracycline contamination: Performance and mechanism (2025 · Industrial Crops and Products · 被引 4)